Infliximab-Abda is a medication that belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It is used to treat a variety of inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, and ankylosing spondylitis.

This medication works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, Infliximab-Abda helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is important to note that Infliximab-Abda is typically prescribed for patients who have not responded well to other treatments or who have severe symptoms that require more aggressive therapy. It is usually administered through intravenous infusion in a medical setting, and the frequency of dosing will depend on the specific condition being treated.

As with any medication, there are potential side effects associated with Infliximab-Abda. These can include infusion reactions, increased risk of infections, liver problems, and a slightly higher risk of certain types of cancer. It is important for patients to discuss these risks with their healthcare provider before starting treatment.

Overall, Infliximab-Abda can be a highly effective treatment option for individuals with inflammatory conditions who have not responded well to other therapies. It is important to work closely with your healthcare provider to determine if this medication is right for you and to monitor for any potential side effects while on treatment.